MarketCap
Xtant Medical Holdings XTNT
$ 0.38
0.15%
Facebook
X
Telegram
Xtant Medical Holdings Accounts Receivables | XTNT
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Xtant Medical Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8 M | 20.7 M | 21.7 M | 10.9 M | 7.15 M | 6.88 M | 10.1 M | 9.99 M | 12.7 M | 19 M | 15.4 M | 4.43 M | 4.79 M | 7.15 M | 7.08 M | 3.52 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.7 M | 3.52 M | 11.2 M |
Quarterly Accounts Receivables Xtant Medical Holdings
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8 M | 17.2 M | 21.7 M | 25.5 M | 27 M | 23.5 M | 20.7 M | 20.5 M | 21.2 M | 21.5 M | 20.7 M | 19.2 M | 13.7 M | 11.9 M | 10.9 M | 9.84 M | - | 7.54 M | 7.15 M | 6.32 M | 6.98 M | 7.03 M | 6.88 M | 6.88 M | 6.88 M | 6.88 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 9.99 M | 9.99 M | 9.99 M | 9.99 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 19 M | 19 M | 19 M | 19 M | 15.4 M | 15.4 M | 15.4 M | 15.4 M | 4.43 M | 4.43 M | 4.43 M | 4.43 M | 4.79 M | 4.79 M | 4.79 M | 4.79 M | 7.15 M | 7.15 M | 7.15 M | 7.15 M | 7.08 M | 7.08 M | 7.08 M | 7.08 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 27 M | 4.43 M | 11.9 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GBS
GBS
|
848 K | - | -0.57 % | $ 7.12 M |  USA |
 |
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
18.6 M | - | - | $ 162 M |  France |
 |
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | USA |
 |
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
123 M | $ 8.47 | 0.71 % | $ 618 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
6.55 M | $ 13.96 | 0.67 % | $ 395 M | USA |
 |
Apollo Endosurgery
APEN
|
15 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
57.2 M | - | - | $ 3.31 B | USA |
 |
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
43.1 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
1.91 M | - | - | $ 10.2 M | USA |
 |
Invacare Corporation
IVC
|
88 M | - | - | $ 24.7 M | USA |
 |
Inogen
INGN
|
38.9 M | $ 5.42 | 0.18 % | $ 144 M | USA |
 |
Integer Holdings Corporation
ITGR
|
346 M | $ 126.5 | 0.8 % | $ 4.39 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 22.41 | 1.17 % | $ 526 M | USA |
 |
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.35 | 0.03 % | $ 21.8 M | USA |
 |
SmileDirectClub
SDC
|
143 M | - | -53.45 % | $ 9.71 M | USA |
 |
Sientra
SIEN
|
36.9 M | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
23.6 M | - | - | $ 1.07 B | USA |
 |
NanoVibronix
NAOV
|
289 K | - | - | $ 1.08 M | USA |
 |
Surgalign Holdings
SRGA
|
16.1 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
115 M | - | - | $ 12.3 B | USA |
 |
NuVasive
NUVA
|
249 M | - | - | $ 2.07 B | USA |
 |
Natus Medical Incorporated
NTUS
|
112 M | - | 1.94 % | $ 1.05 B | USA |
 |
Nevro Corp.
NVRO
|
71.9 M | - | - | $ 217 M | USA |
|
LENSAR
LNSR
|
6.38 M | $ 8.58 | 4.0 % | $ 103 M | USA |
 |
ThermoGenesis Holdings
THMO
|
949 K | - | -25.84 % | $ 171 K | USA |
 |
Talis Biomedical Corporation
TLIS
|
50 K | - | 3.55 % | $ 7.96 M | USA |
 |
LivaNova PLC
LIVN
|
216 M | $ 81.92 | 0.89 % | $ 4.47 B |  Britain |
 |
Butterfly Network
BFLY
|
26.7 M | $ 7.36 | 0.96 % | $ 1.82 B | USA |
 |
Vapotherm
VAPO
|
10.7 M | - | 6.72 % | $ 34 M | USA |
 |
Acutus Medical
AFIB
|
7.88 M | - | -26.83 % | $ 2.62 M | USA |
 |
Globus Medical
GMED
|
679 M | $ 78.29 | 0.27 % | $ 10.6 B | USA |